首页> 美国卫生研究院文献>Aging (Albany NY) >Downregulation of hsa_circ_
【2h】

Downregulation of hsa_circ_

机译:HSA_CIRC_的下调

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Non-small cell lung cancer (NSCLC) is a highly malignant tumor. Many circular RNAs (circRNAs) are reportedly in regulating the progression of NSCLC. To identify potential therapeutic targets for NSCLC, we conducted a bioinformatics analysis of circRNAs differentially expressed between NSCLC tissues and adjacent normal tissues. Hsa_circ_0007580 was upregulated in NSCLC tumor tissues, and the expression of its host gene (protein kinase Ca) correlated negatively with overall survival. Short-hairpin RNAs were used to knock down hsa_circ_0007580 in NSCLC cells, and gene and protein levels were measured with qRT-PCR and Western blotting, respectively. NSCLC cell proliferation, migration and apoptosis were evaluated with CCK-8 assays, Ki-67 staining, Transwell assays and flow cytometry, respectively. Knocking down hsa_circ_0007580 inhibited proliferation and invasion by NSCLC cells and induced their apoptosis. Dual luciferase reporter assays indicated that miR-545-3p can bind to hsa_circ_0007580 (suggesting that hsa_circ_0007580 sponges miR-545-3p) and to protein kinase Ca (suggesting that miR-545-3p directly inhibits this gene). In a xenograft tumor model, downregulating hsa_circ_0007580 inhibited NSCLC tumorigenesis by inactivating p38/mitogen-activated protein kinase signaling. Thus, silencing hsa_circ_0007580 notably inhibited NSCLC progression and , suggesting this circRNA could be a novel treatment target for NSCLC.
机译:非小细胞肺癌(NSCLC)是一种高度恶性肿瘤。据报道,许多循环RNA(Circrnas)正在调节NSCLC的进展方面。为了鉴定NSCLC的潜在治疗靶标,我们进行了在NSCLC组织和相邻的正常组织之间差异表达的CircRNA的生物信息分析。 Hsa_circ_0007580在NSCLC肿瘤组织中上调,其宿主基因(蛋白激酶CA)的表达与总存活负相关。使用短发夹RNA敲击NSCLC细胞中的HSA_CIRC_0007580,并分别用QRT-PCR和Western印迹测量基因和蛋白质水平。通过CCK-8测定,Ki-67染色,转孔测定和流式细胞术评估NSCLC细胞增殖,迁移和细胞凋亡。敲击HSA_CIRC_0007580抑制NSCLC细胞的增殖和侵袭并诱导它们的细胞凋亡。双荧光素酶报告结果分析表明miR-545-3p可以与hs_circ_0007580结合(提示Hsa_circ_0007580海绵miR-545-3p)和蛋白激酶Ca(表明miR-545-3p直接抑制该基因)。在异种移植肿瘤模型中,下调HSA_CIRC_0007580通过灭活P38 /丝亮剂活化的蛋白激酶信号传导来抑制NSCLC肿瘤内酯。因此,沉默的HSA_CIRC_0007580显着抑制了NSCLC进展,并表明该rESCRNA可以是NSCLC的新型治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号